ChemoCentryx Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/22 Q2

ended 03/31/22 Q1

ended 12/31/21 FY 2021

ended 09/30/21 Q3

ended 06/30/21 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Post-effective amendment to an automatic shelf registration

Ownership Filter

Herron Jennifer Lyn

Edwards Thomas A.

Parker Geoffrey M.

News Filter

Amgen Successfully Completes Acquisition of ChemoCentryx

Shareholder Vote Results

Amgen to Acquire ChemoCentryx for $4 Billion in Cash

Announces Appointment of Jennifer L. Herron to Board as Independent Director

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Preliminary proxy related to merger

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Confidential treatment order

Confidential treatment order